Webinars

Register for upcoming (live) or recorded webinars, choose by topic, or search by keyword to find webinars of interest.

Pharmaceutical Regulation

There are a wide range of topics covered under this listing of “regulatory webinars” – from current updates from the FDA and EMA and risk minimization procedures, to issues surrounding IRBs.

November 03, 2020

Pioneering the Evolution of FSP: Not Just for Large Pharma
October 22, 2020

Time for a Clinical Trial Revolution – Complex Innovative Design (CID) Cancer Trials
October 16, 2020

Remote Cardiac Safety Monitoring for Clinical Trials: Through the Pandemic and Beyond
October 09, 2020

Rare Disease Drug Launch – Lessons Learned to Ensure Success is Not a Rare Event
October 08, 2020

How to Minimize Time and Cost of ePRO Translation
October 01, 2020

Addressing the Recent ISO 21973 Guidance: Considerations for Cell and Gene Therapy Distribution
September 30, 2020

Early Access Programs in Europe: ‘A Friend or a Foe’
September 22, 2020

Navigating the Current Landscape for Successful Dermatology Trials
September 10, 2020

Using Early Scientific Advice in Drug Development: Opportunities and Challenges
September 10, 2020

A Comparison of FDA, EMA & PMDA Regulatory Guidance for In Vitro Drug-Drug Interaction (DDI) Assessments
September 04, 2020

An Integrated Development Plan in Rare & Orphan Medicinal Products – Accelerating Time to Approval and Strengthening Asset Value
September 03, 2020

Using Real-World Data in Single-Arm Clinical Trials: When It’s Done, Why It’s Done, How It’s Done
July 17, 2020

Protein Therapeutic Bioanalysis by Hybrid IA-LC-MS/MS: Optimization of a Preclinical Antibody Workflow
July 15, 2020

How to Comply with the New Revision of USP 1058 under a Lockdown
June 22, 2020

COVID-19: Will it be a Catalyst that Moves us Forward in the Drug-Pricing Debate? Or The Barrier that Slows us Down?
May 07, 2020

Strategies for Regulatory Starting Materials Designation in Drug Development and Manufacturing